Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use

By afschroeder • January 26, 2026

Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21. PMID: 41581955.

Tags: Biomarker, Digestive Diseases, DNA methylation, General Internal Medicine, Irritable Bowel Syndrome, microbiome, Publications, Resident, Short chain fatty acids, Volatile organic compounds

Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction

Veraza DI, Waseem MR, Venezia J, Montero AM, Jones S, Kadariya J, Gupta A, Xu H, Shin A. Perceived Utility of Cognitive Behavioral Therapy in[...]

Evaluating the Impact of Different Biliary Stents for Bile Leak Following Fenestrated Cholecystectomy: A Retrospective Multicenter Study

Turner R, Mendez D, Karna R, Liu PH, Issa D, Bilal M, Shah S, Ellis D, Tielleman T. Evaluating the Impact of Different Biliary Stents[...]

Sensory Over-Responsivity in Autism: A Bidirectional Brain-Gut-Microbiome Model

Ringold SM, Cermak SA, Labus JS, Mayer EA, Aziz-Zadeh L. Sensory Over-Responsivity in Autism: A Bidirectional Brain-Gut-Microbiome Model. J Autism Dev Disord. 2026 Mar 4.[...]